These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 28376499)
41. Oligoprenia with congenital glaucoma and pigmentary skin abnormalities in two brothers: a new genetic syndrome. Predescu V; Christodorescu D; Costiner E Rev Roum Med; 1974; 12(6):437-9. PubMed ID: 4462205 [No Abstract] [Full Text] [Related]
42. Dowling-Degos disease with dyschromatosis universalis hereditaria-like pigmentation in a family. Sandhu K; Saraswat A; Kanwar AJ J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):702-4. PubMed ID: 15482301 [TBL] [Abstract][Full Text] [Related]
44. [Cutaneous involvement of amyloidosis associated with multiple myeloma]. Correa H; Giesen L; Vial V; González S Med Clin (Barc); 2016 May; 146(9):e53. PubMed ID: 26589734 [No Abstract] [Full Text] [Related]
45. Friction melanosis, friction amyloidosis, macular amyloidosis, towel melanosis: many names for the same clinical entity. Siragusa M; Ferri R; Cavallari V; Schepis C Eur J Dermatol; 2001; 11(6):545-8. PubMed ID: 11701405 [TBL] [Abstract][Full Text] [Related]
46. [Amyloidosis and the skin]. Chodorowska G Przegl Dermatol; 1981; 68(3):409-14. PubMed ID: 7029665 [No Abstract] [Full Text] [Related]
47. [Normal and abnormal human skin color: from research to esthetics]. Ortonne JP Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S252-6. PubMed ID: 19931680 [TBL] [Abstract][Full Text] [Related]
48. Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura--use of pulsed dye laser, copper vapor laser, and argon laser. Haedersdal M Acta Derm Venereol Suppl (Stockh); 1999; 207():1-32. PubMed ID: 10605602 [TBL] [Abstract][Full Text] [Related]
49. Neurocutaneous disorders: tuberous sclerosis, incontinentia pigmenti, and hypomelanosis of Ito. Wiss K Semin Neurol; 1992 Dec; 12(4):364-73. PubMed ID: 1485046 [No Abstract] [Full Text] [Related]
50. The cutaneous amyloidoses. Pathogenesis and therapy. Breathnach SM Arch Dermatol; 1985 Apr; 121(4):470-5. PubMed ID: 3883907 [No Abstract] [Full Text] [Related]
52. Human and mouse disorders of pigmentation. Spritz RA; Chiang PW; Oiso N; Alkhateeb A Curr Opin Genet Dev; 2003 Jun; 13(3):284-9. PubMed ID: 12787791 [TBL] [Abstract][Full Text] [Related]
53. Amyloidosis cutis dyschromica in a patient with generalized morphoea. Morales Callaghan AM; Vila JB; Fraile HA; Romero AM; Garcia GM Br J Dermatol; 2004 Mar; 150(3):616-7. PubMed ID: 15030364 [No Abstract] [Full Text] [Related]
54. Protein folding and cutaneous diseases. Botelho MG; Lupi O Int J Dermatol; 2008 Dec; 47(12):1225-33. PubMed ID: 19126006 [No Abstract] [Full Text] [Related]
55. Primary cutaneous nodular amyloidosis: case report and review of the literature. Schwendiman MN; Beachkofsky TM; Wisco OJ; Owens NM; Hodson DS Cutis; 2009 Aug; 84(2):87-92. PubMed ID: 19746766 [TBL] [Abstract][Full Text] [Related]
56. A possible pivotal role for transglutaminase 2 in the pathophysiology of cutaneous amyloidosis. Namazi MR Indian J Dermatol Venereol Leprol; 2008; 74(5):521-2. PubMed ID: 19052432 [No Abstract] [Full Text] [Related]